Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure
出版年份 2023 全文链接
标题
Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure
作者
关键词
-
出版物
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
Volume -, Issue -, Pages -
出版商
Canadian Science Publishing
发表日期
2023-09-26
DOI
10.1139/cjpp-2023-0226
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Angiotensin II Type 1A Receptor Expressed in Smooth Muscle Cells is Required for Hypertensive Vascular Remodeling in Mice Infused With Angiotensin II
- (2023) Keisuke Okuno et al. HYPERTENSION
- The mechanism of low-level arsenic exposure-induced hypertension: Inhibition of the activity of the angiotensin-converting enzyme 2
- (2023) Md. Shiblur Rahaman et al. CHEMOSPHERE
- Angiotensin-converting enzyme inhibitory peptide attenuates cardiac hypertrophy associated with ACE2/Ang (1–7)/MasR axis and PKCβ1 pathway
- (2023) Rui Ge et al. Journal of Functional Foods
- Atrial Electrical Remodeling in Mice With Cardiac‐Specific Overexpression of Angiotensin II Type 1 Receptor
- (2022) Julie Demers et al. Journal of the American Heart Association
- Effect of the Renin-Angiotensin System Inhibitors on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled Trials
- (2022) Kamal Awad et al. MAYO CLINIC PROCEEDINGS
- Walnut supplementation after fructose-rich diet is associated with a beneficial fatty acid ratio and increased ACE2 expression in the rat heart
- (2022) Maja Bošković et al. Frontiers in Physiology
- Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy
- (2022) Sukhwinder K. Bhullar et al. Cells
- Sustained AT1R stimulation induces upregulation of growth factors in human cardiac fibroblasts via Gαq/TGF-β/ERK signaling that influences myocyte hypertrophy
- (2022) Ratchanee Duangrat et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The Novel AT2 Receptor Agonist β-Pro7-AngIII Exerts Cardiac and Renal Anti-Fibrotic and Anti-Inflammatory Effects in High Salt-Fed Mice
- (2022) Yan Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Extracellular vesicles DJ-1 derived from hypoxia-conditioned hMSCs alleviate cardiac hypertrophy by suppressing mitochondria dysfunction and preventing ATRAP degradation
- (2022) Yao Lu et al. PHARMACOLOGICAL RESEARCH
- Novel Interactions Involving the Mas Receptor Show Potential of the Renin–Angiotensin system in the Regulation of Microglia Activation: Altered Expression in Parkinsonism and Dyskinesia
- (2021) Rafael Rivas-Santisteban et al. Neurotherapeutics
- Anti-diarrheal therapeutic potential of Diminazene Aceturate stimulation of the ACE II/Ang-(1-7)/Mas receptor axis in mice: a trial study
- (2021) Luan K.M. Souza et al. BIOCHEMICAL PHARMACOLOGY
- Direct Actions of AT 1 (Type 1 Angiotensin) Receptors in Cardiomyocytes Do Not Contribute to Cardiac Hypertrophy
- (2021) Matthew A. Sparks et al. HYPERTENSION
- Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system
- (2021) Michal Herman-Edelstein et al. Cardiovascular Diabetology
- The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
- (2021) Michaela Adamcova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RAAS, ACE2 and COVID-19; a mechanistic review
- (2021) Ahmed Elshafei et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Oxidative Stress as A Mechanism for Functional Alterations in Cardiac Hypertrophy and Heart Failure
- (2021) Anureet K. Shah et al. Antioxidants
- p47phox-Dependent Oxidant Signalling through ASK1, MKK3/6 and MAPKs in Angiotensin II-Induced Cardiac Hypertrophy and Apoptosis
- (2021) Fangfei Liu et al. Antioxidants
- SARS-COV-2 in type 2 diabetic patients: Possible roles of exercise training as a medicine
- (2021) Mehdi Kushkestani et al. CURRENT DIABETES REVIEWS
- Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension
- (2021) Giovanna Castoldi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- COVID-19 and Diabetes: A Comprehensive Review of Angiotensin Converting Enzyme 2, Mutual Effects and Pharmacotherapy
- (2021) Lingli Xie et al. Frontiers in Endocrinology
- Recent Research Advances in Renin-Angiotensin-Aldosterone System Receptors
- (2020) Kengo Azushima et al. CURRENT HYPERTENSION REPORTS
- The Vasoactive Mas Receptor in Essential Hypertension
- (2020) Amalie L. Povlsen et al. Journal of Clinical Medicine
- Delphinidin attenuates pathological cardiac hypertrophy via the AMPK/NOX/MAPK signaling pathway
- (2020) Youming Chen et al. Aging-US
- ACE2, COVID-19, and ACE Inhibitor and ARB Use during the Pandemic: The Pediatric Perspective
- (2020) Andrew M. South et al. HYPERTENSION
- BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy
- (2020) Ermin Li et al. Protein & Cell
- Stretch-Induced Biased Signaling in Angiotensin II Type 1 and Apelin Receptors for the Mediation of Cardiac Contractility and Hypertrophy
- (2020) Kinya Seo et al. Frontiers in Physiology
- Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
- (2020) Silvana Vasile et al. Biomolecules
- Distinct roles of calmodulin and Ca2+/calmodulin-dependent protein kinase II in isopreterenol-induced cardiac hypertrophy
- (2020) Siqi Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ACE2, Much More Than Just a Receptor for SARS-COV-2
- (2020) Lobelia Samavati et al. Frontiers in Cellular and Infection Microbiology
- Angiotensin Receptors Heterodimerization and Trafficking: How Much Do They Influence Their Biological Function?
- (2020) Natalia L. Rukavina Mikusic et al. Frontiers in Pharmacology
- ACE2, Metformin, and COVID-19
- (2020) Atul Malhotra et al. iScience
- Molecular biomarkers in cardiac hypertrophy
- (2019) Liu Zhu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Angiotensin Type 1 Receptor Blockers in Heart Failure
- (2019) Khuraijam Dhanachandra Singh et al. CURRENT DRUG TARGETS
- Nuclear G-protein-coupled receptors as putative novel pharmacological targets
- (2019) Rita Ribeiro-Oliveira et al. DRUG DISCOVERY TODAY
- Counter-regulatory renin–angiotensin system in cardiovascular disease
- (2019) Maria Paz Ocaranza et al. Nature Reviews Cardiology
- Unlocking the Secrets of Mitochondria in the Cardiovascular System
- (2019) Rong Tian et al. CIRCULATION
- Mechanisms for the transition from physiological to pathological cardiac hypertrophy
- (2019) Christopher J. Oldfield et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Alamandine acts via MrgD to induce AMPK/NO activation against ANG II hypertrophy in cardiomyocytes
- (2018) Itamar Couto Guedes de Jesus et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Novel mechanisms of G-protein-coupled receptors functions: AT 1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk
- (2018) András D. Tóth et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of protein phosphatase involvement in the AT 2 receptor-induced activation of endothelial nitric oxide synthase
- (2018) A. Augusto Peluso et al. CLINICAL SCIENCE
- Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders
- (2018) Ewa Szczepanska-Sadowska et al. CURRENT HYPERTENSION REPORTS
- Novel Role for the Immunoproteasome Subunit PSMB10 in Angiotensin II–Induced Atrial Fibrillation in MiceNovelty and Significance
- (2018) Jing Li et al. HYPERTENSION
- Mechanisms of physiological and pathological cardiac hypertrophy
- (2018) Michinari Nakamura et al. Nature Reviews Cardiology
- Critical role of angiotensin II type 2 receptors in the control of mitochondrial and cardiac function in angiotensin II-preconditioned rat hearts
- (2018) Rebeca E. Nuñez et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
- (2018) Steven J. Forrester et al. PHYSIOLOGICAL REVIEWS
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases
- (2018) Maria Angela Incalza et al. VASCULAR PHARMACOLOGY
- Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats
- (2018) Giovanna Castoldi et al. ACTA DIABETOLOGICA
- Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors
- (2018) Alex R.B. Thomsen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice
- (2018) Yoshiki Ogata et al. EUROPEAN JOURNAL OF PAIN
- Myocardial hypertrophy induced by high salt consumption is prevented by angiotensin II AT2 receptor agonist
- (2018) E.P.B. Dopona et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
- (2018) Chen Chen et al. Redox Biology
- CD38 promotes angiotensin II-induced cardiac hypertrophy
- (2017) Xiao-Hui Guan et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- AT2 receptors in cardiovascular and renal diseases
- (2017) Elena Kaschina et al. PHARMACOLOGICAL RESEARCH
- AT1 receptor signaling pathways in the cardiovascular system
- (2017) Tatsuo Kawai et al. PHARMACOLOGICAL RESEARCH
- Centrally Mediated Cardiovascular Actions of the Angiotensin II Type 2 Receptor
- (2017) U. Muscha Steckelings et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Ang-(1-7) is an endogenous β-arrestin-biased agonist of the AT1 receptor with protective action in cardiac hypertrophy
- (2017) Larissa B. Teixeira et al. Scientific Reports
- Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis
- (2016) G. E. Callera et al. BIOSCIENCE REPORTS
- Role of the ACE2/Angiotensin 1–7 Axis of the Renin–Angiotensin System in Heart Failure
- (2016) Vaibhav B. Patel et al. CIRCULATION RESEARCH
- Angiotensin II type 2 receptor (AT2R) in renal and cardiovascular disease
- (2016) B. S. M. Chow et al. CLINICAL SCIENCE
- c-Src Inhibition Improves Cardiovascular Function but not Remodeling or Fibrosis in Angiotensin II–Induced HypertensionNovelty and Significance
- (2016) Glaucia E. Callera et al. HYPERTENSION
- G-Protein–Coupled Receptor MrgD Is a Receptor for Angiotensin-(1–7) Involving Adenylyl Cyclase, cAMP, and Phosphokinase ANovelty and Significance
- (2016) Anja Tetzner et al. HYPERTENSION
- Physiological and pathological cardiac hypertrophy
- (2016) Ippei Shimizu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Angiotensin II type-1 receptor (AT1R) regulates expansion, differentiation, and functional capacity of antigen-specific CD8+ T cells
- (2016) João Luiz Silva-Filho et al. Scientific Reports
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets
- (2015) Yow Keat Tham et al. ARCHIVES OF TOXICOLOGY
- Comparison of angiotensin-(1–7), losartan and their combination on atherosclerotic plaque formation in apolipoprotein E knockout mice
- (2015) Jianmin Yang et al. ATHEROSCLEROSIS
- Hypertension: Renin-Angiotensin-Aldosterone System Alterations
- (2015) L. te Riet et al. CIRCULATION RESEARCH
- Angiotensin type 2 receptors: blood pressure regulation and end organ damage
- (2015) Colin Sumners et al. CURRENT OPINION IN PHARMACOLOGY
- Stimulation of the Angiotensin II AT2 Receptor is Anti-inflammatory in Human Lipopolysaccharide-Activated Monocytic Cells
- (2015) Mario Menk et al. INFLAMMATION
- Pleiotropic Effects of Angiotensin II Receptor Signaling in Cardiovascular Homeostasis and Aging
- (2015) Takehiro Kamo et al. International Heart Journal
- AT2 Receptor Activities and Pathophysiological Implications
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Activation of the cardiac proteasome promotes angiotension II-induced hypertrophy by down-regulation of ATRAP
- (2015) Nan Li et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- From Contractile Enhancement to Pathological Hypertrophy
- (2015) Tetsuro Ago et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen
- (2015) Sourashish Nag et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Angiotensin-(1–7) and angiotensin-(1–9): function in cardiac and vascular remodelling
- (2014) Clare A. McKinney et al. CLINICAL SCIENCE
- Recent insights and therapeutic perspectives of angiotensin-(1–9) in the cardiovascular system
- (2014) Maria Paz Ocaranza et al. CLINICAL SCIENCE
- Angiotensin II and Vascular Injury
- (2014) Augusto C. Montezano et al. CURRENT HYPERTENSION REPORTS
- Angiotensin 1–7 Reduces Mortality and Rupture of Intracranial Aneurysms in Mice
- (2014) Ricardo A. Peña Silva et al. HYPERTENSION
- Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: the role of mitochondria
- (2014) Jessica Soto Hernández et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Redox regulation of cardiac hypertrophy
- (2014) Can M. Sag et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Mitochondrial reactive oxygen species production and respiratory complex activity in rats with pressure overload-induced heart failure
- (2014) Michael Schwarzer et al. JOURNAL OF PHYSIOLOGY-LONDON
- Efeitos cardiovasculares do receptor tipo 2da angiotensina
- (2014) Gabriel Faria-Costa et al. Revista Portuguesa de Cardiologia
- Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Treating Essential Hypertension
- (2013) David B. Matchar et al. ANNALS OF INTERNAL MEDICINE
- ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis
- (2013) AC Simões e Silva et al. BRITISH JOURNAL OF PHARMACOLOGY
- Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension
- (2013) Hiromichi Wakui et al. CARDIOVASCULAR RESEARCH
- The Discovery of the ACE2 Gene
- (2013) A.J. Marian CIRCULATION RESEARCH
- Discovery and Characterization of Alamandine
- (2013) Roberto Queiroga Lautner et al. CIRCULATION RESEARCH
- Angiotensin II type 1 receptor blockade restores angiotensin-(1–7)-induced coronary vasodilation in hypertrophic rat hearts
- (2013) Álvaro P. S. Souza et al. CLINICAL SCIENCE
- Redox signaling in cardiovascular health and disease
- (2013) Nageswara R. Madamanchi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Angiotensin-(1–7) in the Rostral Ventrolateral Medulla Modulates Enhanced Cardiac Sympathetic Afferent Reflex and Sympathetic Activation in Renovascular Hypertensive Rats
- (2013) Peng Li et al. HYPERTENSION
- Angiotensin Type 2 Receptor Stimulation Ameliorates Left Ventricular Fibrosis and Dysfunction via Regulation of Tissue Inhibitor of Matrix Metalloproteinase 1/Matrix Metalloproteinase 9 Axis and Transforming Growth Factor β1 in the Rat Heart
- (2013) Dilyara Lauer et al. HYPERTENSION
- Signaling effectors underlying pathologic growth and remodeling of the heart
- (2013) Jop H. van Berlo et al. JOURNAL OF CLINICAL INVESTIGATION
- Impact of the renin–angiotensin system on cardiac energy metabolism in heart failure
- (2013) Jun Mori et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo
- (2013) F. Billia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- GPCR biased ligands as novel heart failure therapeutics
- (2013) Jonathan D. Violin et al. TRENDS IN CARDIOVASCULAR MEDICINE
- Angiotensin II, NADPH Oxidase, and Redox Signaling in the Vasculature
- (2012) Aurelie Nguyen Dinh Cat et al. ANTIOXIDANTS & REDOX SIGNALING
- Redox Signaling in Cardiac Physiology and Pathology
- (2012) Joseph R. Burgoyne et al. CIRCULATION RESEARCH
- Angiotensin-(1–7): beyond the cardio-renal actions
- (2012) Danielle G. Passos-Silva et al. CLINICAL SCIENCE
- Agonist-Independent Constitutive Activity of Angiotensin II Receptor Promotes Cardiac Remodeling in Mice
- (2012) Noritaka Yasuda et al. HYPERTENSION
- Direct Angiotensin II Type 2 Receptor Stimulation in N ω -Nitro- l -Arginine-Methyl Ester–Induced Hypertension
- (2012) Ludovit Paulis et al. HYPERTENSION
- Mitochondrial function in cardiac hypertrophy
- (2012) Lu-Yu Zhou et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- In Vivo Expression of Angiotensin-(1-7) Lowers Blood Pressure and Improves Baroreflex Function in Transgenic (mRen2)27 Rats
- (2012) Maria A. Garcia-Espinosa et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Angiotensin-converting enzyme 2, angiotensin-(1–7) and Mas: new players of the renin–angiotensin system
- (2012) Robson A S Santos et al. JOURNAL OF ENDOCRINOLOGY
- New therapeutic pathways in the RAS
- (2012) Michael Bader et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Superoxide anions modulate the effects of angiotensin-(1–7) in the rostral ventrolateral medulla on cardiac sympathetic afferent reflex and sympathetic activity in rats
- (2012) P. Li et al. NEUROSCIENCE
- AT2 receptors: beneficial counter-regulatory role in cardiovascular and renal function
- (2012) Shetal H. Padia et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- ACE2, angiotensin-(1–7), and Mas: the other side of the coin
- (2012) Michael Bader PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Regression of pathological cardiac hypertrophy: Signaling pathways and therapeutic targets
- (2012) Jianglong Hou et al. PHARMACOLOGY & THERAPEUTICS
- Promyelocytic Leukemia Zinc Finger Protein Activates GATA4 Transcription and Mediates Cardiac Hypertrophic Signaling from Angiotensin II Receptor 2
- (2012) Ning Wang et al. PLoS One
- Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
- (2012) Monica Flores-Muñoz et al. PLoS One
- Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress
- (2012) Michel Kindo et al. Frontiers in Physiology
- Angiotensin-(1-7)-Mediated Signaling in Cardiomyocytes
- (2012) Enéas R. M. Gomes et al. International Journal of Hypertension
- ROS-induced ROS release in vascular biology: redox-redox signaling
- (2011) Natalya S. Zinkevich et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection
- (2011) Tong Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Mitochondrial oxidative stress mediates induction of autophagy and hypertrophy in angiotensin-II treated mouse hearts
- (2011) Dao-Fu Dai et al. Autophagy
- NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies
- (2011) Alexander Sirker et al. BASIC RESEARCH IN CARDIOLOGY
- Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure
- (2011) Dao-Fu Dai et al. CIRCULATION RESEARCH
- Renin angiotensin system and cardiac hypertrophy after sinoaortic denervation in rats
- (2011) Aline Cristina Piratello et al. Clinics
- Angiotensin II-induced cardiomyocyte hypertrophy in vitro is TAK1-dependent and Smad2/3-independent
- (2011) Sarah J Watkins et al. HYPERTENSION RESEARCH
- The Angiotensin-(1-7)/Mas Receptor Axis Is Expressed in Sinoatrial Node Cells of Rats
- (2011) Anderson J. Ferreira et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice
- (2011) Arun Prasath Lakshmanan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Identification and characterization of a functional mitochondrial angiotensin system
- (2011) P. M. Abadir et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current
- (2010) Jing-Xiang Yin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Angiotensin-(1–7) stimulates high atrial pacing-induced ANP secretion via Mas/PI3-kinase/Akt axis and Na+/H+ exchanger
- (2010) Amin Shah et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- MAPK-Activated Protein Kinase-2 in Cardiac Hypertrophy and Cyclooxygenase-2 Regulation in Heart
- (2010) John M. Streicher et al. CIRCULATION RESEARCH
- Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function
- (2010) Huijing Xia et al. CURRENT HYPERTENSION REPORTS
- Angiotensin II receptors and drug discovery in cardiovascular disease
- (2010) Chiranjib Dasgupta et al. DRUG DISCOVERY TODAY
- The role of inflammatory and fibrogenic pathways in heart failure associated with aging
- (2010) Wei Chen et al. HEART FAILURE REVIEWS
- NADPH oxidases and cardiac remodelling
- (2010) Adam Nabeebaccus et al. HEART FAILURE REVIEWS
- Vascular Relaxation, Antihypertensive Effect, and Cardioprotection of a Novel Peptide Agonist of the Mas Receptor
- (2010) Silvia Quintão Savergnini et al. HYPERTENSION
- Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory Through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor κB
- (2010) Franziska Rompe et al. HYPERTENSION
- Lifetime Overproduction of Circulating Angiotensin-(1-7) Attenuates Deoxycorticosterone Acetate-Salt Hypertension-Induced Cardiac Dysfunction and Remodeling
- (2010) Nívia M. Santiago et al. HYPERTENSION
- The angiotensin AT2 receptor in left ventricular hypertrophy
- (2010) U Muscha Steckelings et al. JOURNAL OF HYPERTENSION
- Novel regulators and drug targets of cardiac hypertrophy
- (2010) Piet Finckenberg et al. JOURNAL OF HYPERTENSION
- Targeting the ACE2–Ang-(1–7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure
- (2010) Michikado Iwata et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Atrap Deficiency Increases Arterial Blood Pressure and Plasma Volume
- (2010) M. Oppermann et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared?☆
- (2010) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies
- (2010) Bianca C. Bernardo et al. PHARMACOLOGY & THERAPEUTICS
- TRPC1 Channels Are Critical for Hypertrophic Signaling in the Heart
- (2009) Malini Seth et al. CIRCULATION RESEARCH
- Angiotensin-(1-7) Prevents Cardiomyocyte Pathological Remodeling Through a Nitric Oxide/Guanosine 3′,5′-Cyclic Monophosphate–Dependent Pathway
- (2009) Enéas R.M. Gomes et al. HYPERTENSION
- The angiotensin II type 2 receptor in cardiovascular disease
- (2009) Catherine A Lemarié et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Adapter proteins and promoter regulation of the angiotensin AT2 receptor — implications for cardiac pathophysiology
- (2009) Heiko Funke-Kaiser et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Losartan Decreases p42/44 MAPK Signaling and Preserves LZ+ MYPT1 Expression
- (2009) Erhan Ararat et al. PLoS One
- Pressure overload-induced hypertrophy in transgenic mice selectively overexpressing AT2 receptors in ventricular myocytes
- (2008) Xinhua Yan et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Regulation of ACE2 in cardiac myocytes and fibroblasts
- (2008) Patricia E. Gallagher et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization
- (2008) Katy Rivard et al. CARDIOVASCULAR RESEARCH
- Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction
- (2008) Justin F.X. Ainscough et al. CARDIOVASCULAR RESEARCH
- Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
- (2008) Chantal Mercure et al. CIRCULATION RESEARCH
- Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation
- (2008) Noritaka Yasuda et al. EMBO REPORTS
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
- Involvement of Nox2 NADPH Oxidase in Adverse Cardiac Remodeling After Myocardial Infarction
- (2008) Yee H. Looi et al. HYPERTENSION
- Molecular Mechanisms Involved in the Angiotensin-(1-7)/Mas Signaling Pathway in Cardiomyocytes
- (2008) Marco F. Dias-Peixoto et al. HYPERTENSION
- Discovery and Validation of Novel Peptide Agonists for G-protein-coupled Receptors
- (2008) Ronen Shemesh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure
- (2008) Slava Epelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduced isoproterenol-induced renin-angiotensin changes and extracellular matrix deposition in hearts of TGR(A1–7)3292 rats
- (2008) Ana Paula Nadu et al. Journal of the American Society of Hypertension
- Angiotensin II AT1 receptor constitutive activation: From molecular mechanisms to pathophysiology
- (2008) Christophe Petrel et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks
- (2008) K.-D. Schlüter et al. PHARMACOLOGY & THERAPEUTICS
- Molecular Mechanisms of Angiotensin II–Mediated Mitochondrial Dysfunction
- (2007) Abdulrahman K. Doughan et al. CIRCULATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now